The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
our MCAP is very low compared to other Wressle players, EDR and UJO. i strongly believe our sp too low even on Wressle alone. so nothing has been priced in for Serenity. so , our sp is currently priced in Serenity as duster! which means i doubt sp will drop lower than here if no success in serenity (if)
sentiment now share price wont rise as much in anticipation of drilling. look at EOG with news on spudding couple of days ago and sp have never been rising beyond and yet now dropping. and EOG is appraisal well and not high risk exploration well.
same will happen with AEX?
yes, you can say i am ramping this, but if you have researched on ANGS and what we are producing and going to produce soon, 5p is easily achievable this year. and on successful sidetrack, we may see 10p very soon too.
this is not good news for Germany
https://twitter.com/Holgerdanske9/status/1570057950802198530
with some people happy to sell at this level, any reason why RAB acquired 4% of SML? what do they see in SML ?
was expected much higher price they able to sell especially in current high oil price.
Now there is a question mark regarding how much can they sell WN (hypothetically) ??
was expected much higher price they able to sell especially in current high oil price.
pls sell, i need to top up a bit lower, say 0.3p ??
some people posted data from website, it seems many thought we were producing below hedged.
in actual fact, per RNS today, we are almost double the amount of hedge!
thats to show many did wrong in reading that data. and many sold previously believing derampers.
now time for ANGS to continue rising to 10p
how much revenue per year?? 100m ?? can someone calculate please,